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ABSTRACT 
 
Master thesis in medicine, Programme of medicine, Sahlgrenska Academy, Gothenburg, Sweden  
Title: 
Ultrasound Based Analysis – a Non-invasive Method to Predict Respiratory Morbidity in the 
Newborn. 
Author, Year: Patricia Johansson, 2014 
Institution: Institution of Clinical Science, Department of Obstetrics and Gynaecology 
Background: 
Approximately 11% of all live births globally are premature, meaning birth before 37 weeks of 
gestation. Preterms are affected by higher rates of mortality and morbidity, especially respiratory 
complications due to the late development of the fetal lungs. One of the most common disorders is 
RDS, Respiratory Distress Syndrome, which is a potentially fatal condition and associated with 
surfactant deficiency. Today the only way of assessing fetal lung maturity is through amniocentesis 
and the amount of surfactant in the amniotic fluid. It is an invasive procedure entailing risks such as 
infection and miscarriage. The possibilities to assess fetal lung maturity through ultrasound based 
quantitative texture analysis have been greatly explored during the last years. A Spanish research team 
has developed an algorithm, QuantUS-FLM with the intention to be able to predict respiratory 
morbidity by quantitative texture analysis of ultrasound images of fetal lungs.  
A similar master thesis project evaluating the predecessor to the current algorithm, AQUA,was 
recently conducted at Sahlgrenska Hospital Östra by medical student Lars Cedergren. During this 
study difficulties for an inexperienced student to obtain ultrasound images of sufficient quality to be 
analysed in the algorithm were discovered. Because of this a quality assurance model to raise the 
number of approved images was developed.  
Aims: 
To explore if ultrasound based quantitative texture analysis is a practicable way of predicting neonatal 
respiratory morbidity. A secondary aim was to evaluate the previous developed quality assurance 
model of ultrasound image acquisition.  
Method: 
41 ultrasound images of fetal lungs from pregnant women admitted to the delivery wards at 
Sahlgrenska Hospital Östra were obtained during October 2013 to Mars 2014. Inclusion criteria were 
gestational weeks 25+0 to 40+0, maternal BMI below 35, no antenatal steroids administrated between 
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the image acquisition and the parturition, delivery occurring within 48 hours from the image 
acquisition and no malformations that could potentially affect the respiratory function. An additional 
37 images obtained by medical student Lars Cedergren were added to the study. The images were then 
analysed with the QuantUS-FLM software online application developed by the Spanish research team. 
A review of both the mother’s and the child’s medical records was done in regards to maternal age, 
maternal conditions and neonatal data. Statistical descriptive analysis was performed using SPSS.  
Results: 
QuantUS-FLM analysed a total of 71 images and predicted 16 as high risk of developing a neonatal 
respiratory morbidity. Among these 16, five neonates developed RDS and two developed another 
respiratory morbidity. None of the 55 neonates that were classified as low risk of developing a 
respiratory morbidity eventually did so.   
Using the quality assurance model developed by a previous master thesis student raised the initial 
approval rate of the first collection phase from 50% in the previously carried out study, to 87% in this 
study.  
Discussion: 
This study might indicate some optimism of the ability of QuantUS-FLM algorithm to predict 
respiratory morbidity through quantitative texture analysis. Due to low incidence of RDS, the 
formation of the study and the student’s pre-requisites for this study a sufficient amount of included 
patients to achieve a moderately strong indication was not achieved. As this is only a local study 
within a larger multicentre study such a number of included patients was, on the other hand, never the 
essential goal. A test that could predict neonatal respiratory morbidity is of special clinical importance 
in the group of neonates born in gestational week 28 to 36 where the obstetrician is facing the 
dilemmas of delivery planning and antenatal steroid administration.  
Conclusions: 
Any conclusions regarding QuantUS-FLM and its ability to predict respiratory morbidity in the 
newborn cannot be made due to lack of power in this study.  
The quality assurance model of image acquisition will likely have contributed to increase the number 
of ultrasound images approved for analysis with the algorithm by the Spanish research team. More 
education and practical training of the student and clearer guidelines concerning optimal image 
features would possibly increase it even more.  
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BACKGROUND 
The purpose of the background text is to create a greater understanding of the strong 
connection between preterm birth and respiratory morbidity. I means of doing so this 
introduction begins with a short summary of the human embryology leading on to the critical 
steps in fetal lung development and neonatal respiratory disorders. It also covers the routines 
of antenatal steroids and fetal lung maturity assessment procedures known today.  Finally it 
will provide an update of the current knowledge and on-going research of ultrasound-based 
methods for fetal lung maturity assessment.  
Basic Embryology 
During a fetus’ third week of development, the trilaminar germ disc is present in the 
blastocyst. It consists of a layer of ectodermal cells, a newly formed layer of mesodermal 
cells, and a layer of endoderm cells. On one side of the trilaminar germ disc is the amniotic 
cavity and on the other side is the yolk sac. It is generally believed that cells of the ectodermal 
layer migrate in the direction of the primitive streak and slip underneath it to form the 
mesodermal layer. This process is called invagination. The mesodermal layer thereafter comes 
in contact with the extra-embryonic mesoderm covering the yolk sac and amnion. The 
mesoderm will give rise to muscles, dermis, subcutaneous tissue of the skin, serous 
membranes, excretory units of the urinary system.  
Cells invaginating the primitive streak will also move straight forward and eventually form a 
solid cord, known as the notochord. The notochord forms the midline axis and will serve as 
the basis of the axial skeleton. The ectoderm covering notochord forms the central nervous 
system. It begins with thickening of the ectoderm, thereafter folding of the lateral edges of the 
neural plate towards the depressed midregion, forming a groove and later the neural tube. This 
tube will give rise to the spinal chord and the brain. The parietal mesoderm and overlying 
ectoderm form the outer body wall.  
The visceral mesoderm and the endodermal layer form the wall of the gut by a folding process 
mainly caused by the rapid longitudinal growth of the central nervous system and the 
transverse folding of the somites derived by mesoderm. This folding process develops an 
endoderm-lined cavity. In the anterior part the foregut is formed, in the caudal region the 
hindgut is formed and in between these two the midgut is formed. The midgut temporarily 
remains in contact with the yolk sac via the omphalomesenteric duct [1]. 
 7 
Fetal lung development 
Normal human lung development is a series of events that has traditionally been divided into 
five phases[2], even though there is a gradually occurred transition of these phases and a 
considerable overlap. The International Congress of Anatomists officially established the 
nomenclature of the first four stages in Leningrad 1970 [3]. There is a great variation between 
phases within a lung’s different areas and the process of lung development is highly 
individual [4]. 
Embryonic stage (Conception-6 weeks of gestation) 
The lung develops as an outgrowth of the ventral wall of the primitive foregut by invasion of 
epithelial cells from the foregut endoderm into the surrounding mesenchyme [4]. Initially the 
outgrow, also known as the respiratory diverticulum, is in open communication with the 
foregut. The foregut and the respiratory diverticulum, or primitive trachea, become separated 
as the diverticulum branches caudally [1] into the main right and left bronchi and thereafter 
continues to branch into lobar and segmental bronchi during week 4-5 [5]. The lobar branches 
correspond to a mature lung in means of three lobar bronchia distally of the right main 
bronchi and two distally of the left [4]. During this phase the pulmonary arteries and veins are 
developed from the sixth aortic arches and accompany the pre-acinar airways and grow 
around the respiratory tubules by vasculogenesis. This process overlaps into the next stage [3, 
5]. 
Pseudoglandular stage (week 6-16) 
In this stage further branching of the airway and vascular network occurs [4] and a total of 20 
generations of branching have occurred by the end of week 16 [3]. The branching pattern is 
regulated by epithelio-mesenchymal interactions [4]. All pre-acinar structures and its vascular 
system are formed during this phase, from the trachea to the terminal bronchioles. Further 
growth and increase in size occurs later on, but there will be no new branches formed after 
this stage [4, 5]. A differentiation of mesechymal cells takes place to form adult structures of 
cartilage in the trachea, bronchial smooth muscle and the presence of mucous glands. 
Columnar cells proximally and cuboidal cells distally, replace the early pseudo-stratified 
epithelium that lined the pre-acinar airways. The cuboidal cells are rich in glycogen and 
represent the immature type II cells [3-5]. Glycogen is an essential part of surfactant that later 
on will be secreted by the pneumocytes type II cells that derive from immature type II cells 
[3]. 
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Canalicular stage (week 16-24) 
The primitive acinar (gas-exchanging) structures are formed in this stage of development and 
consist of respiratory bronchioles, alveolar ducts, sacs and alveoli [5]. There are two 
important steps made in this stage. One is the differentiation of pneumocytes type I and II, 
which is initiated by flattening of acinar epithelium in week 22-24. Pneumocytes type II 
produces surfactant, which is detectable in utero by week 24 but not in sufficient amounts 
until approximately week 30 [2, 4] The other important step in this phase is the beginning of 
the formation of the alveolar-capillary barrier [5]. The lumina increases and vascular networks 
continue to form. At first the vascular networks and the alveolar epithelium are separated by 
mesenchyme, but a gradual decrease in mesenchymal tissue results in capillaries becoming 
more adjacent to the airway epithelium, thus enabling the future gas-exchange [3, 4]. 
Saccular stage (week 24-36) 
A dilation of the acinar tubules takes place to form alveolar saccules - premature alveoli. The 
purpose of the saccular phase is to increase the gas-exchanging surface[4] and during this 
phase the primitive alveoli increase in number and become more and more efficient gas-
exchangers. The alveolar walls are thicker in the saccules than in the final alveoli but the wall 
gradually becomes thinner [2]. A characteristic for this stage is an explicit vascular expansion. 
The blood vessels grow in length and diameter and also form new vessels. An important step 
in the vascular development is the formation of the double capillary layer surrounding the 
saccules [3]. Even though the respiratory structures are not fully developed, they may be able 
to sustain life in a preterm infant [2]. Surfactant is produced in a larger amount during this 
stage and provides the alveoli with stability. It prevents the alveoli from collapsing during 
expiration by reducing the membrane tension of the air-water line in the alveoli [1, 3]. 
Alveolar stage (week 36-8 years of childhood) 
During this phase secondary septa forms, the interstitium and epithelium decrease in thickness 
and the final alveoli develop [2, 6]. These developments also contribute to the lungs 
physiological attributes and thereby the respiratory system in whole. The general 
comprehension is that the first mature alveoli are present at 36 weeks of gestation, marking 
the start of the alveolar stage.  This final phase continues into childhood, and even up to the 
age of 8 years old [2, 4] but with the highest increase of alveoli occurring during the child’s 
first two years [4]. In a fully developed lung there is approximately 300-600 millions alveoli, 
which is about 1000 per acinus[6]. At birth there is approximately 20-50 millions of alveoli 
present [5]. 
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The infant’s first breath 
During the fetal period, the lungs are filled with a fluid secreted by the pulmonary epithelium 
combined with amniotic fluid that the fetus swallows. The amount of fluid existing in a fetal 
lung is not yet completely established but the general opinion is that the volume of fluid is 
larger than the functional residual capacity [7]. The fluid thereby exerts distention to the lungs 
and contributes to maintain a certain lung volume. These factors combined with the breathing 
movements seen in fetuses as early as week 10 are major contributors to lung growth and 
development[5]. The characteristic that marks the infants first breath is the clearance of lung 
liquid from the lungs. This process begins with the onset of labor. Changes in intrauterine 
space during labor changes fetal posture and with that the fetal chest wall configuration. The 
transpulmonary pressure increases and the amount of liquid in the lungs decreases. The fetus 
experiences a large release of adrenaline during labor that promotes the pulmonary epithelium 
to stop secretion and start reabsorption of fluid. Another important process is the fetus’ 
journey through the distal birth canal that exerts compression and stretching of the fetus’ 
thorax. It has been shown that infants born with caesarian section to a lower extent retains air 
at the end of their first breath. Liquid fills the airways until the infant draws its first breath and 
the inspiratory efforts play a critical role in the liquid clearance[7]. 
Antenatal glucocorticoids 
The first positive effects of glucocorticoids in fetal lung maturity were recorded in 1969. A 
study showed that if parturition was induced in sheep at approximately 80% of the normal 
gestation length, the premature lambs were viable if the fetal lambs had been infused with 
dexamethasone [8, 9]. Since then many studies have shown the beneficial effects of antenatal 
glucocorticoids [9]. Antenatal administration of glucocorticoids has proven to reduce both the 
incidence of RDS with 35-45% and the overall neonatal mortality, as well as a reduction in 
the need of neonatal respiratory support [9, 10]. Today glucocorticoids are routinely given to 
women at risk of preterm delivery before 34 weeks of gestation [11, 12]. Betamethasone is 
more potent than dexamethasone and is therefor the drug of choice [10]. 
However, it has been shown that there are no measurable quantities of glucocorticoids in cord 
serum in babies born later than 40 hours since the last betamethasone dose was given. Also 
the effectiveness of antenatal steroids for promoting lung maturation declines after seven 
days[10, 11]. This has resulted in clinical praxis of repetitive administration of antenatal 
glucocorticoids [11] even though there is a lack of scientific evidence that the benefits of this 
outweigh the risks of adverse outcome in the short and long term [12]. Concerns about the 
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risks that antenatal steroids would produce permanent neuromotor and cognitive deficits in 
the newborn have been raised during the recent years. It has been shown that prolonged 
increased levels of glucocorticoids can lead to degeneration of the hippocampus [13]. 
Antenatal steroids have also been shown to elevate fetal blood pressure and also to give rise to 
significant higher blood pressures in children who were treated with antenatal steroids as 
fetuses.  Increased cardiac output through direct effects on the myocardium and a decrease of 
fetal heart rate variability have also been reported [14, 15]. Further antenatal steroids have 
been associated with febrile responses, reduction of lymphocyte proliferation and cytokine 
production and thereby risk of infections[16]. 
Endogenous glucocorticoids 
Many studies have been conducted to understand the effects of glucocorticoids on fetal lung 
development and maturity. The fetus is constantly exposed to cortisol but in a highly 
controlled manner through active transporters in the placenta, liver and brain but also via the 
level of activity of the 11-beta hydroxysteroid dehydrogenase enzyme-family (11β-HSD) in 
the placenta. There are two isoforms of this enzyme: 11 β HSD-1, which convert cortisone to 
the biological active form cortisol and 11 β HSD-2, which converts cortisol back to cortisone. 
In this way, the fetus is protected towards excess levels of endogenous maternal 
glucocorticoids that potentially could cause hyperglycemia and cardiovascular abnormalities. 
The levels of 11β-HSD-1 increases with gestational length and the levels of 11β-HSD-2 
decreases which leads to an increase of cortisol exposure to the fetus at the end of the 
pregnancy [10]. A human fetal lung binds glucocorticoids with high affinity as early as the 
second month of gestation [9]. Circulating levels of cortisol in the fetus are low in comparison 
to the maternal levels but start to increase at about 30 weeks of gestation and rising from 
approximately 14 nmol/L to 125 nmol/lL at term. During labor the levels of cortisol double 
and a few hours after parturition levels of 500 nmol/L have been detected [14]. 
Exogenous glucocorticoids 
Synthetic corticoids such as Betamethasone cannot work as a substrate for the 11-beta 
hydroxysteroid dehydrogenase enzyme-family and is therefore able to cross the placenta and 
act on the fetus’ organs, imitating the action of endogenous cortisol [10]. An immature lung 
responds in a complex way to cortisol and it involves acceleration of surfactant synthesis and 
secretion [3, 17] as well as lung tissue remodeling, cell differentiation and reabsorption of 
lung liquid [3]. Glucocorticoids in its active biological form cortisol, bind to specific 
intracellular receptors located in the pulmonary epithelial type II cells’ cytoplasm, so called 
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glucocorticoid receptors (GR) [8, 9]. The receptor-ligand-complex thereafter translocate into 
the cells’ nucleus and binds to specific DNA-sequences altering its expression. It is believed 
that the altered expression of co-factors accelerates the surfactant synthesis in the immature 
lung after steroid administration [10]. Antenatal glucocorticoids have proven to affect the 
immature lung structure resulting in thinner alveolar walls [9] but produce larger, and fewer 
alveoli in total. It has been indicated that the positive effects by antenatal glucocorticoids may 
be due to the structural implications exclusively [18]. 
Surfactant 
The alveolar walls are made up by a monolayer of type I and type II pneumocytes. The 
pneumocytes type I line 95% per cent of the alveolar walls and form the blood-air-barrier 
together with the basal lamina and endothelial cells. The pneumocytes type II are in contact 
with the alveolar surface only with their apical portion. Pneumocytes type II produce and 
secrete surfactant. A specific characteristic of the pneumocytes type II is the lamellar bodies 
in their cytoplasm. Lamellar bodies are storage units of surfactant that can be secreted into the 
alveolar space by exocytosis [19]. Surfactant is a lipoprotein complex[20], which is a mix of 
lipids (90% of total weight) and proteins (10% of total weight). There is also a very small 
amount of carbohydrates, less than 0,1% of total weight. 90% of the lipids consist of Lecithin 
and Phospholipids and the role of lipids in surfactant is to lower the surface tension. The 
proteins are of great importance in the adsorption process of the lipids to the air-water 
interface [19]. There are four types of surfactant protein; SF-A, SF-B, SF-C and SF-D. The 
surfactant proteins are divided into two groups depending on their attributes. SF-A and SF-D 
are hydrophilic surfactant proteins that regulate the surfactant secretion and recycling and also 
play a role in the lung’s immune response system [17]. SF-B and SF-C are hydrophobic and 
are the hydrophobic proteins that play a role in the biophysical surfactant functions [21]. The 
biophysical functions of surfactant are to lower the surface tension of the alveoli, support the 
alveolar stability during the respiratory cycle, allow alveoli of different sizes to function with 
equal efficiency, increase lung compliance, help maintain the gas exchange area of the lung, 
counteract pulmonary edema through balancing of hydrostatic forces and to reduce the work 
of breathing [17, 21]. In summary the pulmonary surfactant prevents the lung from collapsing 
at low lung volumes [20].   
Preterm birth and respiratory morbidity 
Approximately 11% of all live births globally are preterm and prematurely born infants 
constitute a relatively large compound of the newborn deaths. Preterm birth is defined as birth 
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before 37 completed weeks of gestation and is subdivided into very preterm birth (birth before 
34 weeks of gestation) and extremely preterm birth (birth before 27 completed weeks of 
gestation) [16, 18]. Preterm infants are affected by all forms of respiratory morbidity at a 
higher rate than infants born in a more advanced gestational week [2]. Many preterm infants 
do not have an adequate spontaneous respiration at birth and require assisted ventilation [22]. 
Respiratory illness is the single most common cause of neonatal mortality and morbidity [18]. 
The most common causes of respiratory distress are respiratory distress syndrome, transient 
tachypnea of the newborn and meconium inspiration syndrome.  
Respiratory distress syndrome, RDS 
RDS is the most common cause of respiratory distress in premature infants, and is also known 
as hyaline membrane disease. It has been established to correlate with structural and 
functional lung immaturity [23]. It is described as respiratory distress in infants that sets in 
within a few hours of parturition. The incidence of RDS is inversely proportional to 
gestational length and has been estimated to range from 30% below gestational week 28 to 
5% in neonates born in a gestational week above 34 [17, 23, 24]. Surfactant deficiency was 
proven to be the cause of RDS as early as 1959 [9, 25]. Insufficient amounts of surfactant 
cause small alveoli to deflate and larger alveoli to overinflate, which creates a mixed situation 
of atelectasis and overdistention [26]. In turn, atelectasis causes pulmonary vascular 
constriction, hypoperfusion and lung tissue ischemia [23]. The name, hyaline membrane 
disease, is originated by the findings that insufficient amount of surfactant causes fibroblasts 
to invade the alveoli and alter the membranes’ thickness [3]. There are also components of 
pulmonary interstitial edema and cellular debris in these hyaline membranes [26]. Thicker 
membranes compromise the alveolar exchange of oxygen and carbon dioxide and cause 
respiratory distress [3].  
Clinical symptoms of RDS are grunting, chest wall retractions, tachypnea, hypoxia and 
cyanosis in a premature infant immediately after birth. Typical signs in a chest-x-ray are 
homogenous infiltrates [23] that are commonly called “ground glass opacy” and signs of 
atelectasis [18, 23]. The introduction of antenatal steroids and surfactant therapy has markedly 
increased the survival rate of infants suffering from RDS [26]. Antenatal steroids decrease the 
incidence of RDS with approximately 50% and surfactant treatment reduces the severity of 
RDS, the progression of the disease and the incidence of death associated with RDS [18]. 
According to the European Consensus Guidelines on management of neonatal respiratory 
distress syndrome 2013 mechanical ventilation should be avoided, and when possible a non-
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invasive ventilation such as the CPAP should be used instead due to the risk of lung injury 
[12]. Research indicates that early surfactant treatment, at or within minutes of birth, 
combined with initiation of nasal CPAP significantly reduces the need for mechanical 
ventilation and chronic lung disease [25-28].  
Transient tachypnea of the newborn, TTN 
This condition is the second most common respiratory disease in premature infants [29]. It is 
a benign condition that occurs when the timing of lung fluid clearance has failed and lung 
fluid remains in the lungs after parturition [23]. The risks of TTN are high in infants who are 
born precipitously, without active labour or with caesarean section [29]. It is a condition that 
usually requires minimal intervention and resolves over a 24 to 72h period but may however 
cause severe morbidity such as hypoxia and respiratory distress and give rise to unnecessary 
use of antibiotics [30]. The most typically occurring symptom is tachypnea at or within two 
hours of birth and chest x-ray can show signs of excess lung fluid such as diffuse infiltrates, a 
“wet siluette” surrounding the heart or intralobar fluid accumulations [23].  
Persistent pulmonary hypertension, PPHN 
Pulmonary hypertension in the newborn is generally believed to be caused by failure of the 
normal cardiopulmonary transition at or shortly after birth [31]. During the fetal life, most of 
the blood returning to the right atrium directly proceeds into the left atrium through the 
foramen ovale. Blood entering the right ventricle shunts through the ductus arteriosus and 
flows directly in to the aorta [32] resulting in that less than 15% of the combined ventricular 
cardiac output perfuses the lungs [33]. Before birth, the resistance in the pulmonary arteries 
are very high due to low oxygen tension in the alveoli. As the infant starts to breath air at the 
parturition, the resistance in the pulmonary arteries rapidly decreases as the oxygen tension in 
the alveoli increases. This reaction is mediated by mitochondrial production of ATP that in 
turn stimulates eNOS to produce nitride oxide causing pulmonary vasorelaxation [32]. Other 
mediators such as prostacyclin (PGI2) have also been detected in this reaction. In addition to 
this there is another mechanism of decreased levels of active vasoconstrictors [31]. When this 
transition fails, the pulmonary artery resistance remains high and as a result the blood is 
continuously being shunted into the systemic circulation due to persistent foramen ovale and 
ducuts arteriosus [34]. This bypassing of the pulmonary circulation leads to severe 
hypoxemia, which in turn may be therapy resistant against oxygen treatment [31, 35]. Risk 
factors of developing PPHN are intra uterine growth restriction, maternal SSRI exposure and 
NSAID exposure in utero during third trimester. Even though inhalation of NO is regarded as 
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the golden standard, PPHN still has a considerable high mortality rate. Therefor ECMO 
treatment is recommended when pharmacological treatment fails [32].  
Lung maturity tests by amniocentesis 
In 1996 and then again in 2008 [36, 37] The American College of Obstetricians and 
Gynaecologists recommended the assessment of fetal lung maturity before elective deliveries 
at less than 39 weeks of gestation because of the risk of neonatal RDS [38, 39]. Predictive 
tests of RDS through amniocentesis have been available since 1971 [40]. The main 
indications for lung maturity testing have been to discriminate foetuses in high risk of 
developing RDS from those who will not have a significant respiratory disease [41]. It is 
currently performed for the purpose of delivery planning concerning patients with 
complicated pregnancies [42, 43]. In many conditions preterm delivery is not possible to 
avoid and fetal lung maturity testing is of less value in these cases. Because of this it has been 
suggested that lung maturity testing preferably should be considered more important when the 
time of delivery is elective, such as in cases with premature rupture of membranes or placenta 
praevia and accrete, when advanced gestation may cause increased risk for both mother and 
foetus [42].  
However, there have been studies reporting that there has been a decrease in the amount of 
lung maturity tests performed in the US the last years. The studies have shown that this is due 
to physicians’ opinions that lung maturity testing is not medically necessary for patient care, 
concerns about the risks of amniocentesis and patients’ refusal of amniocentesis. Still, only a 
small number of the physicians participating in the survey agreed to the statement that they 
could provide the same level of care without the benefaction of lung maturity test results 
available today [40, 41]. The American College of Obstetricians and Gynaecologists released 
new recommendations this year and do no longer recommend fetal lung maturity testing for 
the reason that if preterm delivery is necessary it should not be delayed because of the lung 
maturity test results. On the other hand if it is possible to safely delay the delivery, there is no 
actual indication for preterm delivery [44]. These guidelines are in accordance with the 
Swedish tradition concerning lung maturity testing and preterm deliveries.  
Due to the fact that fetal lung liquid is directly communicating with the amniotic fluid the 
assessments available today are based on indirect estimation of the amount of surfactant 
through amniocentesis [17]. To be clinically useful fetal lung maturity tests should have a 
high diagnostic sensitivity and high negative predictive value. Unfortunately, the tests 
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available today continue to be relatively poor predictors of lung maturity. One study showed 
that 10% of children born to hospitalized women with mild preeclampsia after a positive lung 
maturity test still developed RDS. This indicates that there needs to be improvements in fetal 
lung maturity tests available today [17, 42].  
Lecithin/Sphingomyelin ratio 
This was the first produced biochemical assessment for fetal lung maturity. Lecithin is a 
surfactant lipid and increases in concentration during the third trimester. Sphingomyelin is a 
surfactant phospholipid but remains relatively consistent throughout the pregnancy and can 
therefore be used as an internal standard against which lecithin concentrations may be 
compared. The concentrations are determined by thin layer chromatography. A minimum of 
3-4 ml of amniotic fluid is required and the current cut-off point for lung maturity is a ratio of 
2,0. The L/S ratio have been proven to have a relatively good sensitivity but lack of 
specificity [17]. The method is difficult to perform and interpret and it also requires a few 
hours for analysis [39]. Another disadvantage is the fact that contamination of the amniotic 
fluid of either blood or meconium can influence the ratio to either a positive or negative 
outcome [17].  
Phosphatidylglycerol 
The existence of phosphatidylglycerol (PG) occurs several weeks later than Lecithin and is 
considered a late marker of lung maturity. When detectable, it is a very strong indicator that 
RDS will not occur. Phosphatidylglycerol is not present in either blood or meconium, which 
is a major advantage. In 1983 an immunochemical approach to detection of PG was reported 
and it was based on the agglutination of antibodies with PG containing lamellar bodies. This 
biochemical assessment was named Amniostat FLM. It is rapid and not affected by meconium 
or blood but because of the late appearance of phosphatidylglycerol, many infants that test 
immature never develop RDS. Even so the test does demonstrate a high negative predictive 
value [17].   
Surfactant/Albumin ratio 
The surfactant/albumin ratio is the most commonly used test today and is based on the 
competitive binding of a fluorescent probe to pulmonary surfactant and albumin in the 
amniotic fluid. It has been improved since the development in 1976. The last modification 
was made in 1995 and the method was renamed to TDx FLM II Assay. Recommendations by 
the manufacturer have set the cut-off levels to over 50 for mature lung and beneath 39 for 
immature lung. Several studies have shown the TDx FML II assay to have excellent 
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sensitivity but to its disadvantage not quite as good specificity. The national Academy of 
Clincial Biochemistry recommended the surfactant/albumin ratio to become the standard 
routine analysis of fetal lung maturity [17]. A study has shown the correlation between 
antenatal administrated corticosteroids and increase in the TDx FML II value the following 
week. This is interpreted to strengthen the fact that antenatal steroids enhance lung maturity 
and that the TDx FML II value is a relevant predictor of the fetal lung maturity [43]. 
Lamellar body count 
Surfactant is stored as lamellar bodies in the cytoplasm of the pneumocytes type II cells. The 
lamellar bodies are secreted into the alveolar space and release surfactant. This assessment 
method is based on a standard haematological cell counter to quantify the number of lamellar 
bodies in the amniotic fluid [17]. It is possible to use the haematological cell counter because 
of the fact that lamellar bodies are similar in size to platelets [39, 45]. Counts >50 000/μL 
estimates maturity and counts <15 000/μL suggests immaturity[17]. A disadvantage of the 
method is that results may differ depending of the brand of the blood cell counter but 
advantages are that it is inexpensive and a relatively simple test [42, 45, 46]. Studies have 
shown LBC to be equal the L/S ratio in sensitivity and specificity and LCB is also suggested 
to be equal surfactant/albumin ratio, even though no studies directly have compared the two 
[17, 45]. It is recommended that either lamellar body count or TDx FML II Assay should be 
performed as an initial test for prediction of lung maturity since both these methods are rather 
rapid [17, 47]. 
Risks associated with amniocentesis 
The general risks associated with amniocentesis are leakage of amniotic fluid, pregnancy loss, 
infection, failure to obtain a sample and thereby multiple needle punctures, contamination of 
amniotic fluid with blood and possibly, but rarely, direct fetal injury [48-50]. Most of the 
publications on this matter are studies made on amniocentesis for chromosomal analysis 
indication. A miscarriage risk of 1 in 200 is widely quoted and was published by the 
American College of Obstetricians and Gynaecologists in 2001. These numbers are 
approximately the same for women that have not gone through amniocentesis [51], making it 
difficult to know whether the miscarriage is due to the amniocentesis or to unrelated events 
[48]. Another conclusion that can be made is that amniocentesis is a relatively safe method 
performed by experienced practitioners [51]. Some studies have shown an additional risk of 
pregnancy loss at 0,6% compared to control groups that do not go through amniocentesis. 
They also prove that ultrasound guidance during the amniocentesis lower the incidence of 
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pregnancy loss, multiple needle punctures and the contamination of the amniotic fluid with 
blood [48]. The risk of pregnancy loss is naturally a great concern in the women about to 
undergo amniocentesis and the risk is clearly small but nevertheless existing [50].  
Previous literature on ultrasound based assessment of fetal lung maturity 
The basic idea of ultrasonography is to send a fine beam of ultrasound waves through the 
human tissues to receive characteristic echo reflections and form an ultrasound image. The 
different grey levels in the image represent the acoustic properties of the tissue such as 
attenuation of acoustic waves, speed of sound and acoustic impedance [52]. Ultrasound can 
not measure biochemical changes in the growing lung nor histological changes but it is 
reasonable to assume that both morphological and biochemical changes alter the propagation 
properties in the fetal lung [53]. The possibilities of using ultrasound as a non-invasive 
method for assessment of fetal lung maturity, have been greatly explored over the last 30 
years [54]. A lot of earlier studies have shown that the echogenicity of the fetal lung changes 
as the pregnancy progresses and also in relation to other fetal organs such as the liver, 
placenta and fetal gut [53, 55].  
A drawback in ultrasonography diagnosing is that it is in general very subjective and 
dependent on the sonographer’s ability to observe certain textural characteristics from the 
image and compare them with those developed for different pathologies in order to determine 
if a disease or abnormality exists or not. In order to solve this problem a computer based 
quantitative texture analysis model has been developed and it has proven favourable results 
when diagnosing liver-, breast- and thyroid diseases [52]. Due to the previous results the 
method was found interesting to use in fetal lung maturity assessment. A few studies have 
shown encouraging results in this field with evident changes in fetal lung texture correlating 
with increasing gestational age and also when compared to fetal liver textural characteristics 
[52, 53, 56]. Unfortunately because of controversial results, limitations in sample size and 
difficulties in recording the parameters in standardized ways, development of the results into 
clinically applicable solutions has so far been prevented [54].  
Recently a Spanish research team led by M.D Ph.D Montse Palacio has developed a 
quantitative ultrasound analysis algorithm, AQUA, that has been proven to be able to extract 
features from fetal lung that strongly correlate with gestational age [57]. The same algorithm 
has also been proven to correlate with TDx-FLM results with a sensitivity of 95,1%, a 
specificity of 85,7% and an accuracy rate of 90,3% in predicting mature and immature fetal 
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lungs [54]. Those results are the basis of a current multicentre study, originating from 
Barcelona, Spain, now examining the clinical usefulness of the quantitative texture analysis 
algorithm [58].  
Procedures of ultrasound image acquisition 
During the summers of 2012 and 2013, medical student Lars Cedergren executed his master 
thesis project in medicine at Sahlgrenska University Hospital Östra, examining the clinical 
usefulness of quantitative texture analysis of fetal lungs to predict respiratory morbidity using 
the AQUA algorithm. In the summer of 2012, the Spanish research team approved only 21 out 
of 40 obtained images for analysis, which gave an approval rate of only 52,5%.  
To ensure that more images met the distributed guidelines and would be approved in the 
future, Lars Cedergren launched a new model for quality assurance.  This involved proper 
introduction to the ultrasound machine for future new students and the institution of a quality 
control checkpoint before images analysis. The checkpoint was constituted of an experienced 
physician in fetal ultrasound diagnostics that would double-check the images and select the 
preferable image to be sent for analysis. The student would give his or her suggestions of 
which image to be selected and the physician would either agree or disagree and give 
feedback in return to the student. This new quality assurance model resulted in a 100% 
approval rate in the summer of 2013 [59].  
 
Fig.1. Flow chart visualizing the proceedings of the quality assurance method developed 
by medical student Lars Cedergren in 2013 regarding ultrasound image acquisition.  
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AIMS 
The primary aim of this project is to determine if ultrasound based quantitative texture 
analysis of fetal lungs is a practicable method to predict the risk of neonatal respiratory 
morbidity. 
The secondary aim is to evaluate the quality assurance method developed by Lars Cedergren 
in image acquisition.  
 
 
METHOD 
Literature review 
To collect background information and to become conversant with the current knowledge 
about the subject, a non-structured literature review was undertaken. PubMed was the solitary 
used database and the search terms used were different terms concerning fetal lung maturity 
and development, premature births and respiratory complications, assessment of fetal lung 
maturity and former research concerning ultrasonography and fetal lung maturity testing. 
Some articles were found through suggested related searches. The student alone without 
supervision or verification has conducted the literature review.  As this is not supposed to be a 
structured literature review, the journals impact factor has not been taken into account.  
 
Collection of ultrasonography images  
This project is part of a large multicentre prospective observational study originating from the 
Department and Research Centre of Maternal-Fetal Medicine, Hospital Clínic-IDIBAPS in 
Barcelona, Spain. There are a total of 17 institutes from 10 different countries participating in 
this study, among them Sahlgrenska University Hospital, Gothenburg. The goal of the 
multicenter study is to gather at least 1000 images divided in a minimum of 200 between 25 
to 30 weeks of gestation, 300 between 31-35 weeks of gestation and 500 at 36-40 weeks of 
gestation to achieve a statistical difference. This was measured using the prevalence of RDS, 
approximated to 20% overall, and the estimations that 200 cases would be enough to make an 
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adequate difference. The Spanish research team has not conducted any power calculations. 
Each participating clinical center should be providing at least 50 images and preferably 100-
300. 
Inclusion criteria were women delivering between 25+0 and 40+0 weeks of gestation and in 
which an ultrasound image of the fetal lungs is acquired within 48 hours prior to delivery. 
Exclusion criteria were maternal steroids administered after the ultrasound image acquisition 
and before delivery, fetal malformations that could potentially affect lung maturity and 
maternal body mass index greater than 35. Images collected of fetuses that were delivered 
after more than 48 hours after the ultrasound image acquisition were deleted [58]. 
Images were collected during a period of 25 weeks, from October 2013 to March 2014. The 
images were primarily collected at the special delivery ward with ultrasound machine 
Voluson model E. The student was introduced to the ultrasound machine and to the 
proceedings of fetal diagnostics at two occasions in October 2013. The first included patient 
was informed and the first image acquisition was done with supervision. Thereafter the 
student obtained all the ultrasound images without further supervision. When images had been 
obtained and delivery had occurred within 48 hours, up to five suggested images were 
uploaded to drop box for evaluation of quality and selection for analysis according to Lars 
Cedergren’s previous developed process [59]. The images were evaluated and selected by 
M.D Panagiotis Tsiartas. The ultrasound images had to be close-up cross-sections of the fetal 
thorax with a four-chamber view of the heart. To achieve as high quality as possible for the 
developed analysis method, guidelines were distributed from the Spanish research team (see 
figure 2).  
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Fig.2. Guidelines on how to obtain an optimal image for analysis with QuantUS-FLM 
 
 
Data collection procedures 
If the delivery occurred within 48 hours, a review of both the mother’s and the newborn’s 
medical records were performed concerning certain medical aspects (see table 1). These data 
were filled into an excel-document and double-checked by the Spanish research team before 
the analysis to exclude any type of incongruences. The excel-document originated from Spain 
and all the clinical centers involved in this study filled in an equal document. The medial 
record reviews were mostly conducted 48-72h after the delivery. If it was a full-term delivery 
without neonatal complications, the review was only conducted at this one time. If the 
neonate was admitted to the NICU, a review of its medical records was conducted repeatedly 
until discharge.  
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Tab.1. Medical aspects registered for each included patient.  
 
Quantitative texture analysis 
Quantitative imaging techniques of medical images are based on the development of an 
algorithm to improve the information obtained from the images. The purpose is to extract 
quantitative information from an image to detect non-visible changes and to be more of an 
objective path for prediction and diagnosis [60]. In other words, to turn subtle non-visible 
 
1. ID patient (individual code)  19. NICU admission (yes/no) 
2. US Scan Machine (Brand)   20. Date of NICU admission (if any) 
3. US Scan Machine (Model)   21. Date of NICU discharge (if any) 
4. Last menstrual period (by 1st trimester scan) 22. Use of oxygen therapy >40% (yes/no) 
5. Date of scan   23. Respiratory support (yes/no) 
6. Date of amniocentesis (if any)  24. Nasal CPAP (yes/no) 
7. Test of lung maturity used (if any)  25. Nasal NIV/BIPAP (yes/no) 
8. Value of test of lung maturity (if any)  26. Mechanical ventilation or endotracheal intubation  
9. Result of test of lung maturity (if any)        (intubation) (yes/no) 
10. Date of 1st steroid dose   27. Days of intubation (if any) 
11. Date of 2nd steroid dose   28. HFV – high frequency ventilation (yes/no) 
12. Date of delivery   29. Surfactant (yes/no) 
13. Gestational age at delivery  30. Courses of surfactant (if any) 
14. Mode of delivery (spontaneous vaginal delivery, 31. Respiratory distress (yes/no) * 
operative vaginal delivery, elective ceasarian section, 
non-elective cesearian section)     
15. Birthweight   32. Transient tachypnea of the newborn (yes/no) 
16. Apgar 1’    33.Other respiratory disorders (yes/no) ** 
17. Apgar 5’    34. Describe other respiratory disorder ** 
18. Umbilical artery pH   35. Describe other relevant conditions *** 
 
*Definition of RDS: 
Early onset of the following signs: tachypnea, tachycardia, chest wall retractions (recession), expiratory grunting, nasal flaring and cyanosis during breathing 
efforts associated at least a reticulogranular pattern on chest film or oxygenation response to surfactant. As the disease progresses, the newborn may develop 
ventilatory failure (decreasing oxygen levels and rising carbon dioxide concentrations in the blood) and prolonged apneas 
** Include: PPH (persistent pulmonary hypertension), apnea, pneumothorax 
 
*** Include: Pneumonia, meningitis, sepsis workup, sepsis (culture proven) or NEC (necrotizing enterocolitis), seizures or convulsions, IVH (intraventricular 
hemorrhage) grade I-II or IVH grade III-IV, hypoglycemia, feeding problems, TPN (total parenteral nutrition), hypothermia, hyperbilirubinemia, or jaundice 
requiring phototherapy 
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image information into a numeric score and by those means compare it with other digital 
images [61]. The Spanish research team initially developed a custom made quantitative 
texture analysis algorithm, AQUA (automatic quantitative ultrasound analysis) that was 
developed to be invariant under illumination changes because it did not use the direct grey 
level in the image [62]. It estimates texture features based on conditional random fields (CRF) 
in a manner in which the texture features robustly converges to different tissue characteristics, 
independently to the overall acquisition context, such as scanning settings and operator skills 
[54, 62]. A conditional random field is a form of graphic statistical model often used for 
image segmentation and to combine features from different sources [62].  
 
QuantUS-FLM- algorithm 
The AQUA-algorithm was however found not to be robust enough and was further developed 
into a new algorithm, the QuantUS-FLM (QuantusFLM®, Transmural Biotech, SL, 
Barcelona, Spain). QuantUS-FLM is a mathematical classification algorithm especially 
designed to predict neonatal respiratory morbidity through the analysis of textural image 
features from fetal lung images. The software is composed of two modules: 
1. Texture feature extractor module 
2. Classification module 
The texture feature extractor module has already previously been optimized to select 
ultrasound image textural features that are more characteristically identifying fetal lung and 
that are more robust to variations occurring in image acquisition in clinical practice. The 
module was developed by combining several existing mathematical methods for texture 
extraction, in different iterations, using theoretical samples and real ultrasound images.  In 
total the development used more than 10 million image samples and over 7 billion 
computerized experiments.  
The second module, the classification module, is based on an algorithm that combines 
gestational age and the texture features obtained with the first module to predict the 
occurrence of neonatal respiratory morbidity. The algorithm used in this module is the result 
of computer training process using machine-learning methods that combined different 
mathematical approaches with lung ultrasound images from more than 1000 real clinical 
cases[63].  
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Analysis with QuantUS-FLM 
The images were digitally collected in the DICOM (Digital Imaging and Communication in 
Medicine) format. All images were uploaded to Spain where the research team approved them 
and uploaded them anonymously to their newly developed software application for on-line 
analysis. The student manually processed each image with a manual delineation of each lung 
so that no tissue except lung-tissue would be analysed by the software. The application does 
not check the user’s delineation, and a poorly performed delineation may compromise the 
results. It is important that the delineated area is as wide as possible, of the proximal lung (in 
relation to the ultrasound probe) and not containing any blood vessels or other structures such 
as the heart, diaphragm or ribs (see figure 3).  
 
Fig.3. Visualization of the manual delineation process in the QuantUS-FLM online 
application.  
After the delineation process the QuantUS-FLM software was applied to extract the texture 
features of the delineated parts of the lungs. For each image submitted, a result of either low 
risk or high risk (for developing respiratory morbidity) is received within minutes of the 
analysis, which is an on-line procedure done through the QuantUS-FLM custom made 
application. A visualization of the process of this study is showed in figure 4. When all 
images had been run through analysis the Spanish research team sent a file in which the IDs 
of the images were revealed.  
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Fig.4. Flow chart visualizing the image collecting process and analysis with QuantUS-
FLM.  
Statistical analysis 
The statistical analyses have been done using SPSS and have been performed with 
supervision of Dr Tsiartas. All statistical analyses are based on the data retrieved from the 
medical record review. No comparative analyses have been used, solely descriptive analyses. 
The calculation of birth weight deviation score (Table 3) has been made using the Marsal 
method [64] taking gender, birth weight and gestational age at delivery under account to 
calculate the deviation from estimated expected birth weight. This calculation was done by 
PhD student Jonas Bacelis.  
ETHICS 
Women admitted to the two delivery wards at the Sahlgrenska University Hospital/Östra were 
invited to participate in the study. They were given an oral presentation about the study as 
well as a written brochure and thereafter asked to sign a consent form stating that they had 
received the information given to them and agreed to participate out of free will. The 
ultrasonography-images collected were solely containing clinical information. Each 
participant was given an individual code only known to the person collecting the images. Any 
requests from the parents, regarding other ultrasonography diagnostic procedures such as 
malformation- or gender evaluation during the image collection, were rejected due to the 
student’s limited diagnostic competence. This local study received an ethical approval by 
Regional Ethical Review Board in Gothenburg on March 19, 2012 (application approval 
number 184-12).   
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RESULTS 
A total of 59 images of individual foetuses were collected during this study. Of these 15 were 
excluded due to delivery beyond 48 hours from the image acquisition, two were excluded due 
to maternal BMI above 35 and one was excluded because of delivery before gestational week 
25+0. The remaining 41 images that fulfilled the inclusion criteria were uploaded to drop box 
was Dr Tsiartas double checked the quality and select one of the suggested images to be 
analysed. Due to the low number of included patients a third classification of images were 
installed during the double check procedure, in addition to approved and unapproved, which 
was named uncertain of sufficient quality. These seven uncertain images were also sent for 
analysis but with the knowledge that they would most likely be disapproved. Two images 
were discarded during the double check procedure and 39 images were thereby sent to Spain 
to be anonymized and thereafter analysed in the online application.  
In the end, five images were unapproved due to poor image quality by the Spanish research 
team, although only two of these had been classified as uncertain and the remaining three had 
been classified as approved during the double check procedure. In summary, a total of 34 
images was eventually analysed of the images collected in the time period 30-10-13 to  
31-03-14, which provides an approval rate of 87%. 37 images of neonates with no respiratory 
outcome, collected by medical student Lars Cedergren, were added to the 34 images collected 
by Patricia Johansson. The results below are based on the merged total of 71 images analysed 
by QuantUS-FLM, collected during 14-06-12 to 31-03-14.  
Fig. 5. Flow chart visualizing the number of images existing in this study and the 
distribution of approved and discarded images.  
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Tab. 2. Maternal Demographics and Neonatal Data  
 
 
 
	  	   Neonates with respiratory  Neonates without respiratory  
  morbidity n=7 (9.9%) morbidity n=64 (90.1%) 
Maternal age (years, median, IQR*) 31 (8) 31 (7) 
Nulliparous (n=, %) 4 (57.1%) 36 (56.3%) 
Preeclampsia 2 (28.6%) 12 (18.8%) 
PTL 2 (28.6%) 5 (7.8%) 
PPROM 2 (28.6%) 2 (3.1%) 
Twin pregnancy 2 (28.6%) 8 (12.5%) 
Antenatal steroids (n=, %) 7 (100%) 5 (7.8%) 
Vaginal delivery (n=, %) 3 (42.9%) 49 (76.6%) 
Caesarean section (n=, %) 4 (57.1%) 15 (23.4%) 
Gestational age at delivery (weeks+days, median, IQR*) 26+3 (32 days) 38+1 (16 days) 
25+0 to 27+6 4 (57.1%) 0 
28+0 to 33+6 3 (42.9%) 4 (6.2%) 
34+0 to 36+6 0 9 (14.1%) 
37+0 to 40+0 0 51 (79.7%) 
Birth weight (gr, median, IQR*) 850 (1390-670) 3200 (3485-2750) 
0 to 1000g 5 (71.4%) 0 
1001 to 2000g 2 (28.6) 4 (6.2%) 
2001 to 3000g 0 20 (31.3%) 
3001 to 4000g 0 35 (54.7%) 
4001 to 5000g 0 5 (7.8%) 
NICU* admission (n=, %) 7 (100%) 11 (17.2%) 
APGAR* score < 7 (n=, %)     
at 1 min 6 (85.7%) 8 (12.5%) 
at 5 min 1 (14.3%) 1 (1.6%) 
*	  IQR	  =	  Interquartile	  range.	  PTL=	  Preterm	  labour,	  PPROM=	  Preterm	  premature	  rupture	  of	  membranes,	  NICU=	  Neonatal	  intensive	  care	  unit.	  APGAR=	  Test	  of	  neonatal	  
viability	  in	  regards	  to	  appearance,	  pulse,	  grimace,	  activity	  and	  respiration	  assessed	  at	  1	  minutes	  and	  5	  minutes	  after	  birth.	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As showed in table 2 the maternal age and parity are equally distributed between the group of 
neonates with and the group without respiratory morbidity. Maternal conditions seem to be 
more commonly occurring in the group with respiratory morbidity and the neonates are born 
with caesarean section to a greater extent when observing these numbers. Neonates in the 
group with respiratory morbidity were of much lower gestational age at delivery, following a 
much lower birth weight and constitute a higher percentage of neonates with APGAR score 
below 7 at 1 minute. All of the neonates with respiratory morbidity were admitted to the 
neonatal intensive care unit compared to 17,2% of the group without respiratory morbidity. 
 
 
 
Fig.6. Distribution of QuantUS-FLM results in relation to gestational age at delivery 
expressed in days. 
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Fig.7. Distribution of QuantUS-FLM results in relation to gestational age at delivery 
expressed in weeks+days.  
Seven of the neonates developed a respiratory morbidity and all of them were correctly 
classified as high risk with QuantUS-FLM. Another nine neonates were also classified as high 
risk of developing respiratory morbidity without actually developing respiratory morbidity. 
Within the group of low-risk none developed a respiratory morbidity. As visualized in figure 
6 the low risk classified neonates were existent in gestational ages at delivery above 28 weeks 
of gestation and high-risk classified neonates existed in gestational ages below 36 weeks of 
gestation which formed a small overlap. The main quantity of low risk classified neonates was 
above 35+5 weeks of gestation at delivery (visualized in figure 7). 
The Spanish research team were requested to confirm the accuracy of the received results. 
M.D. PhDc Teresa Cobo re-delineated the 71 images and received a result that was 94,4% 
consistent to the results above. Two of the neonates that did not develop a respiratory 
morbidity but nevertheless were classified as high risk turned out as low risk in the second 
analysis. Further on two of the neonates classified as low risk but never developed a 
respiratory morbidity were in opposite classified as high risk in the second analysis.  
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Tab.3. Maternal and neonatal characteristics in the group of neonates with high risk 
QuantUS-FLM results.  
 
 
Nine individuals were classified as high risk and did not develop a respiratory morbidity. 
They are described in more detail in table 2. All were born between 32 weeks of gestation to 
36 weeks of gestation and had a close to equal amount of maternal conditions as the true 
positives. Only two of them received antenatal steroids and the weight-deviation score varied 
from -36,8% to +32,1%. Vaginal delivery, induced or spontaneous, was overly represented in 
this group of neonates. 
 
 
  
Respiratory 
outcome 
GA at delivery 
(weeks+days) 
Maternal 
morbidity 
Antenatal 
steroids 
Type of 
delivery 
Admission to 
NICU >1 week 
Weight-
deviation score 
1 RDS 26 +3 Preeclampsia Yes NCS Yes -37,8% 
2 TTN 31+1 Preeclampsia Yes NCS Yes -24,1% 
3 Other 30+6 PPROM Yes NCS Yes -19,4% 
4 RDS 26+2 PTL Yes IVD Yes -14,7% 
5 RDS 26+2 PTL Yes IVD Yes -12,7% 
6 RDS 25+3 PPROM Yes SVD Yes +3,1% 
7 RDS 29+3 GH, IUGR Yes NCS Yes -55,7% 
8 None 35+2 PTL No SVD Yes -19,9% 
9 None 36+0 PTL No SVD No +4,4% 
10 None 35+0 Vaginal bleeding No IVD No -2,0% 
11 None 34+4 Preeclampsia No IVD No -11,2% 
12 None 36+1 No No IVD No -15,2% 
13 None 36+0 Preeclampsia No IVD Yes -36,8% 
14 None 33+4 GH Yes 
NCS (failed 
induction) Yes -31,1% 
15 None 32+1 PTL Yes ECS No -6,6% 
16 None 35+4 PTL No SVD No +32,1% 
RDS=	  Respiratory	  distress	  syndrome,	  TTN=	  Transient	  tachypnea	  in	  the	  newborn,	  Other	  =	  see	  previous	  specification,	  in	  this	  case	  apnea,	  PPROM=	  Preterm	  premature	  rupture	  of	  membranes,	  PTL=	  preterm	  labour,	  IUGR=	  Intrauterine	  growth	  
restriction,	  GH=	  Gestational	  hypertension,	  NCS=	  Non-­‐elective	  caesarean	  section,	  IVD=	  Induced	  vaginal	  delivery,	  SVD	  =	  Spontaneous	  vaginal	  delivery,	  ECS=	  Elective	  caesarean	  section,	  NICU=	  Neonatal	  intensive	  care	  unit	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DISCUSSION 
The results in this master thesis project might indicate some optimism concerning QuantUS-
FLM’s ability to predict neonatal respiratory morbidity.  
§1 Clinical Relevance  
The most interesting results are the overlap of high risk and low risk test results in the 
gestational ages 28+0 to 33+6 and 34+0 to 36+0. These are the groups of pregnancies with the 
most clinical relevance. In these groups the obstetrician is facing decisions concerning 
delivery planning and has to balance the benefits of a preterm birth on both mother and child 
against the obvious risks of preterm births for the neonate. A reliable test that could predict 
the risks of respiratory complications if delivered within 48 hours would strengthen the 
comprehensive assessment of each case. Also antenatal steroids are not routinely given in the 
group of neonates born in gestational week 34-36 due to the uncertain long-term adverse 
effects (see background). A theoretical possible way of using a high-risk result in this group 
would be to use as an indication for antenatal steroids. Also, as stated in some published 
articles on the subject, a non-invasive test that could predict fetal lung immaturity could be 
used repeatedly to estimate the effects of the antenatal steroids given[65].  
Unfortunately there are not enough patients included in this study to be able to see any real 
indications. QuantUS-FLM did detect all of the neonates that developed respiratory morbidity 
but only three of these were born in the overlapping groups discussed above and none of these 
were born in week 34+0 to 36+0.  
Research in a larger scale on the subject is currently on going at the Clinical Hospital, 
Barcelona, Spain, led by M.D Ph.D. Montse Palacio and M.D Ph.D. Teresa Cobo. As 
described earlier their study is formed as a multicentre study in which several clinical centres 
and countries are involved to gain more power to their results. The data collection phase of 
this study was recently closed and any results have yet not been released. The intentions are to 
publish an article, which already has been sent to the Journal Of Obstetrics and 
Gynaecologists for approval. Previous studies of the predecessor to QuantUS-FLM, AQUA, 
have shown that the algorithms results strongly correlate to gestational age and also to fetal 
lung maturity testing with TDx-FLM [54, 57]. It will be interesting to see the results and to 
compare them to other non-invasive ultrasound based methods to predict fetal lung maturity 
such as fetal lung to liver ratio. That method has recently proven in one study to predict fetal 
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lung immaturity with a prediction rate of 96%[65]. The future will have to state which method 
really is the most practicable in clinical praxis.  
§ High risk neonates 
Nine neonates were predicted to develop RDS, TTN or other respiratory morbidity but did 
not. Three of these were admitted to NICU but none were in need of any respiratory support. 
The drawback of receiving results such as this in a clinical situation is the risk of prolonging a 
complicated pregnancy when is not really necessary. A prolonged pregnancy can in certain 
situations entail risks for both mother and child. No neonates were predicted to not develop a 
respiratory morbidity but eventually did anyway. That is promising results since it would 
possibly be devastating in a clinical situation.  
No general conclusions could be made of these nine individuals that would explain why they 
received a high-risk result without developing respiratory complications. Vaginal delivery is 
more commonly occurring in this group, which may have contributed to the fact that none of 
these nine neonates developed a respiratory morbidity. That point of view would be cohesive 
with an epidemiological study conducted in Gothenburg 1986, which stated that RDS is more 
commonly occurring in neonates that were born trough caesarean section compared to vaginal 
delivery[66].  
A higher amount of high-risk results were observed in neonates with low birth weight and low 
gestational age at delivery. A possible explanation is the fact that the algorithm takes under 
account the gestational age at delivery in the analysis. The gestational age of delivery has 
previously been proven to be a strong predictor of respiratory morbidity[67], naturally, and 
therefor must be included in such an algorithm. Also the texture of the fetal lungs differs 
along the gestational age and therefor it is a very strong factor and important to include in the 
algorithm. Perhaps the software needs to be custom made for different gestational ages to 
ensure that gestational age at delivery does not work as a confounder. There is a risk that the 
QuantUS-FLM is more likely determining whether a foetus is preterm or full-term than 
actually predicting the risk of neonatal respiratory morbidity.  
§Analysis process	  
In this study the delineation and analysis results was made by and received directly by the 
student. This is an advantage in an educational point of view as the student were given the 
opportunity to take part in each step of the project giving a comprehensive view. In a more 
scientifically point of view it would have been better if a blinded and more experienced 
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person would have made the delineation as the student only had a few months of experience 
in evaluating ultrasonography-images of fetal lungs. There are primarily two risks with having 
the same person collecting the image and later doing the delineation in a study like this. The 
first is the risk that not only lung tissue got analysed because of poor delineation and the 
second that the person doing the analysis could try to manipulate the results because of 
knowledge of the real outcome. On the other hand, this is a clinical study of a diagnostic test 
that is intended to be used by obstetricians at delivery wards who will both be collecting the 
images and perform the delineation process. 
The advantages of the QuantUS-FLM are that it is fairly easy for physicians and other health 
care professions to use the on-line application as well as the results are received very quickly, 
within minutes of approval of analysis. The ultrasound image is also relatively easy to collect, 
and especially to obstetricians and gynaecologist used to working with ultrasound diagnostic 
procedures. There is no need to take under account a long period of training of image 
acquisition and the acquisition is not time consuming. Ultrasonography is also a very gentle 
diagnostic method with no maternal or neonatal adverse outcomes. It does not come with any 
pronounced discomfort or risks associated with the invasive methods.  
§Power 
A disadvantage of this master thesis project is the low power it holds. This could partly be 
explained by the pre-requisites and formation of the study combined with the low incidence of 
RDS and other neonatal respiratory complications. These factors led to difficulties in 
achieving enough included patients as would have been statistically desirable. As this is only 
a local project within a larger multicentre study this was never an achievable goal, although a 
higher number of included patients would have provided stronger indications regarding the 
ability of QuantUS-FLM to predict respiratory morbidity.   
§Formation of the study 
In this master thesis project the student was not able to spend time at the delivery ward every 
day due to other classes in parallel. To be able to make good timings of ultrasound image 
acquisitions in relation to delivery, it has become evident during this project that it is of great 
importance that the researcher can indeed spend a lot of time at the delivery wards, being well 
informed by the physicians concerning the possible candidates health and delivery status. The 
strategy in this study was to collect ultrasound images of the possible candidates that fulfilled 
the inclusion criteria when possible and then delete the images if delivery did not occur within 
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48 hours. The disadvantage of not being able to spend time at the delivery wards every day 
lead to missing to include a lot of neonates who eventually developed a respiratory morbidity. 
This disadvantage is something to take into account when developing similar projects in the 
future. Important to mention is the impossibility to predict whether a foetus will or will not 
develop RDS and also the difficulties in estimating whether or not a foetus will be delivered 
within 48 hours from the image acquisition. The inclusion criteria provided a very small time 
window in which the image could be obtained and this combined with the student’s pre-
requisites made it even more difficult.  
With some help from neonatologist Dr Lennart Stigsson we were able to receive some 
statistics of the local incidence of RDS in Gothenburg through the Perinatal Quality Register, 
and also the number of neonates admitted to NICU the last year. A total of 30 neonates 
developed RDS during almost the entire image-collecting phase of this study and these were 
also delivered between 25+0 to 40+0 weeks of gestation. Four of these were included in this 
study, which represents 13,3% of the possible RDS patients. This indicates that if more 
continuous time could have been spent at the delivery ward a higher percentage of included 
neonates that were born with respiratory complications would possibly have been achieved.  
§Evaluation of the quality assurance model of image selection 
The quality assurance model introduced by Lars Cedergren has proven to pay off when 
introducing new students to the proceeding of ultrasound image acquisition. During his first 
image-collecting phase he received an approval rate of 52% and in this study the student 
received an approval rate of 87%. This indicates that proper introduction and education at the 
beginning and thereafter close check ups and quality control checkpoints may play a part in 
the increase of approval rate. Although, regarding the double-check procedure, since all the 
images classified as uncertain of sufficient quality was sent for approval to the Spanish 
research team it was found that only two of the seven uncertain images got disapproved in the 
end but in opposite three images that had been classified as approved eventually got 
disapproved by the Spanish research team. This raises question marks to whether the 
approval/disapproval process is a very subjective process or if even clearer guidelines and 
image examples should be provided for each clinical centre.  
 
 
 35 
CONCLUSIONS AND IMPLICATIONS 
Due to lack of power this study cannot provide any conclusions except a small indication that 
the QuantUS-FLM algorithm could possibly be a practicable method to predict the risk of 
neonatal respiratory morbidity. To be able to draw any reliable conclusions the study 
population would have had to been a great deal larger.  
Conclusions concerning the quality assurance model in image acquisition are that it may have 
contributed to the increase the number of approved images for a first time student. If further 
improvements are made in introduction and education in ultrasound diagnostic technique as 
well as becoming more consistent in the double check procedure it might be possible to even 
further increase the approval rate.  
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Populärvetenskaplig sammanfattning 
Ultraljudsbaserad analys – en icke-invasiv metod för att förutspå andningsstörningar hos nyfödda 
Globalt sett är ungefär var tionde födsel som sker för tidig, vilket brukar menas att barnet föds 
innan graviditetsvecka 37. De svårigheter som barnen kan drabbas av är framförallt 
andningsstörningar. Detta beror på att fosters lungor utvecklas väldigt sent, ungefär i 
graviditetsvecka 24 och är egentligen inte helt färdigutvecklade ens när barn föds i fullgången 
tid. Detta kan leda till ett tillstånd som kallas RDS, Respiratory Distress Syndrome, vilket 
innebär att lungorna hos barnet inte är helt färdiga och saknar ett viktigt ämne som håller 
lungblåsorna öppna så att barnet kan tillgodose sig med syre. Detta ämne kallas surfaktant. 
Andra vanliga andningsstörningar är till exempel att barnet har kvar fostervatten i lungorna 
längre än de ska och behöver syrgas eller att barnet drabbas av andningsuppehåll och behöver 
andningsstöd av respirator.  
Det finns tillstånd där förlossningsläkare väljer att förlösa ett barn trots att det är för tidigt på 
grund av att det utgör en hälsorisk för både mamma och barn om graviditeten fortsätter. Det är 
i sådana situationer ett test som kan förutsäga om fostret är redo att förlösas eller inte med 
avseende på andningen hade varit viktigt. Detta för att förlossningsläkaren då kan vänta med 
förlossningen om det behövs och är möjligt.  
Idag kan man mäta fosters lungmognad genom ett fostervattensprov där man försöker mäta 
mängden surfaktant i fostervattnet. Detta är en invasiv metod där en nål sticks in i mammans 
livmoder och fostervatten som omger fostrets sugs ut. Detta medför obehag och risker som 
infektioner efteråt, läckage av fostervatten genom hålet och en mycket liten, men inte 
obefintlig risk för missfall. Detta görs idag inte i Sverige på grund av att man inte tycker att 
det är en tillräckligt bra metod. I Spanien försöker man nu istället utveckla ett datorprogram, 
QuantUS-FLM, som ska kunna tolka ultraljudsbilder på fosters lungor och förutsäga om de 
har en risk för att drabbas av andningsstörningar efter en förlossning. Detta examensarbete är 
en del av Spaniens multicenterstudie där flera olika länder deltar. Ett liknande examensarbete 
har nyligen gjorts av en annan student där man visade att det kan vara svårt som student att 
kunna ta tillräckligt bra ultraljudsbilder. Den studenten utvecklade då ett system för att 
introducera och lära nya studenter att ta tillräckligt bra bilder och det systemet vill vi också 
utvärdera hur det fungerar.  
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Studiens genomförande: 
Vi samlade in ultraljudsbilder på fosters lungor från gravida kvinnor som av olika anledningar 
låg inne på Östra sjukhusets specialförlossning- eller normalförlossningsavdelning i 
graviditetsvecka 25 till 40. Bilderna togs inom 48 timmar till en förlossning och efter 
förlossningen dokumenterades hur barnet mådde med avseende på andningen och om 
mamman hade några sjukdomar i botten. Dessa bilder tolkades senare i ett datorprogram där 
man fick ett resultat som sade antingen hög risk för att drabbas av andningsstörning eller låg 
risk.  
Studiens resultat: 
Datorprogrammet klassificerade alla barn som drabbades av andningsstörning som hög risk, 
men även nio andra barn klassificerades som hög risk utan att drabbas av andningsstörning 
efter förlossningen. Av alla barn som klassificerades som låg risk drabbades ingen av någon 
andningsstörning.  
I det tidigare genomförda examensarbetet av en annan student blev nästan hälften av bilderna 
underkända för att de var av för dålig kvalitet. I den här studien blev bara 15 % underkända.  
Slutsatser av studien: 
På grund av att studien enbart innehåller bilder från totalt 71 foster är det inte tillräckligt för 
att kunna dra några vetenskapliga slutsatser kring resultatet. Mer forskning behöver göras, 
vilket pågår i större skala i Spanien just nu men några resultat har ännu inte fåtts fram. Man 
kan se en indikation att datorprogrammet fungerar. En nackdel av falska positiva testresultat, 
det vill säga de foster som felaktigt klassificeras som hög risk utan att drabbas av 
andningsstörning, är att det i kliniska situationer kan leda till att man låter en komplicerad 
graviditet fortsätta längre än man borde för att testet felaktigt säger att fostret behöver det.  
Denna studie visade även att det introduktions- och kvalitetssäkringssystem som utvecklades 
av den föregående studenten fungerar med avseende på att öka andelen bilder som blir 
godkända för analysering med QuantUS-FLM.  
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